Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Drug companies are harnessing new knowledge of cancer genetics.
Researchers use electric fields to get cancer drugs directly to tumors.
Foundation Medicine will provide a personalized picture of a patient’s disease.
A startup is targeting diseases including cancer using epigenetic approaches.
Understanding the different populations of mutant cells in a cancer could mean more targeted treatments.
Scientists use synthetic biology to create drug-controlled T cells.
Sequencing the genomes of both healthy and cancer cells from the same patient hints at how cancer metastasizes.
A new approach to treating bone cancer is being tested in pet dogs.
A number of dual-action antibodies are in clinical trials for fighting cancer.